Proton pump inhibitors and acute kidney injury: A nested case-control study

BMC Nephrology

Volumn 14, Issue 1, 2013, Pages

  Klepser, Donald G ^a   Collier, Dean S ^a   Cochran, Gary L ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Kidney failure; Nephritis; Proton pump inhibitors; Renal disease

Indexed keywords

PROTON PUMP INHIBITOR;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; CASE CONTROL STUDY; CLINICAL FEATURE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; EFFECT SIZE; FEMALE; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; RETROSPECTIVE STUDY; ACUTE KIDNEY INJURY; CHEMICALLY INDUCED; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL;

ACUTE KIDNEY INJURY; ADULT; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PROTON PUMP INHIBITORS; RETROSPECTIVE STUDIES;

EID: 84880091246     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-14-150     Document Type: Article

References (30)

1. IMS health Top-line market data: 2009 U.S. Sales and prescription information: http://www.imshealth.com/portal/site/ims/menuitem. d248e29c86589c9c30e81c033208c22a/?vgnextoid= 9c61ba440c900310VgnVCM10000071812ca2RCRD&cpsextcurrchannel=1
2. Wickersham RM, Novak KK, Drug facts and comparisons St. Louis, MO: Wolters Kluwer Health, Inc 2005
3. Clinical pharmacology of proton pump inhibitors: what the practising physician needs to know. Robinson M, Horn J, Drugs 2003 63 2739 2754 10.2165/00003495-200363240-00004 14664653
4. SURVEIL (study of undetected reactions, vigilance enquiry into links) group: mortality study of 18 000 patients treated with omeprazole. Bateman DN, Colin-Jones D, Hartz S, Langman M, Logan RF, Mant J, Murphy M, Paterson KR, Rowsell R, Thomas S, Vessey M, Gut 2003 52 942 946 10.1136/gut.52.7.942 12801948
5. Guide to the use of proton pump inhibitors in adult patients. Boparai V, Rajagopalan J, Triadafilopoulos G, Drugs 2008 68 925 947 10.2165/00003495- 200868070-00004 18457460
6. Proton pump inhibitor formulary considerations in the acutely ill. Part 2: clinical efficacy, safety, and economics. Devlin JW, Welage LS, Olsen KM, Ann Pharmacother 2005 39 1844 1851 10.1345/aph.1G176 16204393
7. Acute interstitial nephritis due to omeprazole. Ruffenach SJ, Siskind MS, Lien YH, Am J Med 1992 93 472 473 10.1016/0002-9343(92)90181-A 1341422
8. Drug-induced tubulo-interstitial nephritis secondary to proton pump inhibitors: experience from a single UK renal unit. Torpey N, Barker T, Ross C, Nephrol Dial Transplant 2004 19 1441 1446 10.1093/ndt/gfh137 15004262
9. Proton pump inhibitors and acute interstitial nephritis. Geevasinga N, Coleman PL, Webster AC, Roger SD, Clin Gastroenterol Hepatol 2006 4 597 604 10.1016/j.cgh.2005.11.004 16630752
10. Proton pump inhibitors and acute interstitial nephritis: report and analysis of 15 cases. Simpson IJ, Marshall MR, Pilmore H, Manley P, Williams L, Thein H, Voss D, Nephrology (Carlton) 2006 11 381 385 10.1111/j.1440-1797.2006. 00651.x
11. Systematic review: proton pump inhibitor-associated acute interstitial nephritis. Sierra F, Suarez M, Rey M, Vela MF, Aliment Pharmacol Ther 2007 26 545 553 10.1111/j.1365-2036.2007.03407.x 17661758
12. Proton pump inhibitors and the kidney: critical review. Brewster UC, Perazella MA, Clin Nephrol 2007 68 65 72 17722704
13. Drug-induced acute interstitial nephritis. Rossert J, Kidney Int 2001 60 804 817 10.1046/j.1523-1755.2001.060002804.x 11473672
14. Acute interstitial nephritis: immunologic and clinical aspects. Ten RM, Torres VE, Milliner DS, Schwab TR, Holley KE, Gleich GJ, Mayo Clin Proc 1988 63 921 930 10.1016/S0025-6196(12)62697-4 3045437
15. The outcome of acute interstitial nephritis: risk factors for the transition from acute to chronic interstitial nephritis. Schwarz A, Krause PH, Kunzendorf U, Keller F, Distler A, Clin Nephrol 2000 54 179 190 11020015
16. Drug-induced renal failure: a focus on tubulointerstitial disease. Markowitz GS, Perazella MA, Clin Chim Acta 2005 351 31 47 10.1016/j.cccn.2004. 09.005 15563870
17. Review of drug-induced acute interstitial nephritis. Murray KM, Keane WR, Pharmacotherapy 1992 12 462 467 1492011
18. Diagnosis and management of acute interstitial nephritis. Kodner CM, Kudrimoti A, Am Fam Physician 2003 67 2527 2534 12825841
19. Acute kidney injury following proton pump inhibitor therapy. Brewster UC, Perazella MA, Kidney Int 2007 71 589 593 10.1038/sj.ki.5002038 17164832
20. Acute renal failure after myeloablative hematopoietic cell transplant: incidence and risk factors. Hingorani SR, Guthrie K, Batchelder A, Schoch G, Aboulhosn N, Manchion J, McDonald GB, Kidney Int 2005 67 272 277 10.1111/j.1523-1755.2005.00078.x 15610251
21. Pharmacoepidemiology II: the nested case-control study-a novel approach in pharmacoepidemiologic research. Etminan M, Pharmacotherapy 2004 24 1105 1109 10.1592/phco.24.13.1105.38083 15460170
22. Use of antiepileptic drugs and risk of fractures: case-control study among patients with epilepsy. Souverein PC, Webb DJ, Weil JG, Van Staa TP, Egberts AC, Neurology 2006 66 1318 1324 10.1212/01.wnl.0000210503.89488.88 16682661
23. Impact of decreasing patient cost share on medication switching: results from a zero-dollar generic copayment program. Klepser D, Pantelogianis A, Huether JR, Williams CE, J Manag Care Pharm 2009 15 202 203
24. Effect of a cost-sharing change from copayment to coinsurance on drug expenditures and utilization. Klepser DG, Huether JR, Handke LJ, Williams CE, J Manag Care Pharm 2007 13 765 777 18062728
25. Use of propensity scores to control for baseline characteristics in a comparison of health care utilization. Klepser DG, Champ A, Huether JR, Williams C, J Manag Care Pharm 2012 18 202
26. Predictors of new-onset kidney disease in a community-based population. Fox CS, Larson MG, Leip EP, Culleton B, Wilson PW, Levy D, JAMA 2004 291 844 850 10.1001/jama.291.7.844 14970063
27. Socio-demographic factors influence use of proton pump inhibitors among users of nonsteroidal anti-inflammatory drugs. Van Boxel OS, Hagenaars MP, Smout AJ, Siersema PD, Clin Gastroenterol Hepatol 2009 7 855 861 10.1016/j.cgh.2009. 05.017 19465157
28. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. Deyo RA, Cherkin DC, Ciol MA, J Clin Epidemiol 1992 45 613 619 10.1016/0895-4356(92)90133-8 1607900
29. Early steroid treatment improves the recovery of renal function in patients with drug-induced acute interstitial nephritis. Gonzalez E, Gutierrez E, Galeano C, Chevia C, De Seqera P, Bernis C, Parra EG, Delgado R, Sanz M, Ortiz M, Goicoechea M, Quereda C, Olea T, Bouarich H, Hernandez Y, Segovia B, Praga M, Grupo Madrileno De Nefritis Intersticiales, Kidney Int 2008 73 940 946 10.1038/sj.ki.5002776 18185501
30. Gordis L, Epidemiology Philadelphia, PA: W. B. Saunders Company 1996 277